Additional data analysis offers greater insight into phase 2 findings of Bionomics’ PTSD drug

Image: Bionomics’ BNC21 has showed significant effect in phase 2 post traumatic stress disorder trial. Photo: courtesy of everydayplus / FreeDigitalPhotos.net.